glp-1 shortage update FDA Ends Compounding of Drugs as Shortages Improve, The U.S. Food and Drug Administration (FDA) has announced the end of the for GLP-1 weight loss drugs like Ozempic, leading to the glp-1 news updates november 2025

Was taking, on my recommendation, 15,000 IUs of D3 and was still deficient in D3

For the study, which was published in the journal Molecular and Cellular Neuroscience , researchers reviewed findings from 30 preclinical studiesmostly on animals and cellsthat looked at the impact on signs of Alzheimers disease of four GLP-1 receptor agonists: liraglutide (Victoza, Saxenda), semaglutide (Ozempic, Wegovy), exenatide (Byetta), and dulaglutide (Trulicity)

They are particularly beneficial for individuals with conditions like pernicious anaemia, digestive disorders, or those recovering from surgery that affects nutrient absorption

296, no